These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 6698632)
1. Plasma exchange (PE) and lymphocytapheresis (LCA) in multiple sclerosis (MS). Höcker P; Stellamor V; Summer K; Mann M Int J Artif Organs; 1984 Jan; 7(1):39-42. PubMed ID: 6698632 [TBL] [Abstract][Full Text] [Related]
2. Lymphocytapheresis therapy in multiple sclerosis, a preliminary study. Medaer R; Eeckhout C; Gautama K; Vermijlen C Acta Neurol Scand; 1984 Aug; 70(2):111-5. PubMed ID: 6485745 [TBL] [Abstract][Full Text] [Related]
3. Plasma exchange in the management of patients with multiple sclerosis: preliminary observations. Valbonesi M; Garelli S; Mosconi L; Zerbi D; Forlani G Vox Sang; 1981; 41(2):68-73. PubMed ID: 7331281 [TBL] [Abstract][Full Text] [Related]
4. Plasmapheresis, lymphocytapheresis, and immunosuppressive drug therapy in multiple sclerosis. Hauser SL; Fosburg M; Kevy S; Weiner HL Prog Clin Biol Res; 1982; 106():239-54. PubMed ID: 6184727 [TBL] [Abstract][Full Text] [Related]
5. Plasma exchange for steroid-refractory relapses in multiple sclerosis: an observational, MRI pilot study. Meca-Lallana JE; Hernández-Clares R; León-Hernández A; Genovés Aleixandre A; Cacho Pérez M; Martín-Fernández JJ Clin Ther; 2013 Apr; 35(4):474-85. PubMed ID: 23541130 [TBL] [Abstract][Full Text] [Related]
6. Lymphocytapheresis in chronic progressive multiple sclerosis: immunologic and clinical effects. Hauser SL; Fosburg M; Kevy SV; Weiner HL Neurology; 1984 Jul; 34(7):922-6. PubMed ID: 6539868 [TBL] [Abstract][Full Text] [Related]
7. Double-blind study of true vs. sham plasma exchange in patients treated with immunosuppression for acute attacks of multiple sclerosis. Weiner HL; Dau PC; Khatri BO; Petajan JH; Birnbaum G; McQuillen MP; Fosburg MT; Feldstein M; Orav EJ Neurology; 1989 Sep; 39(9):1143-9. PubMed ID: 2549450 [TBL] [Abstract][Full Text] [Related]
8. [Therapeutic apheresis in multiple sclerosis]. Nomura K Nihon Rinsho; 2003 Aug; 61(8):1388-95. PubMed ID: 12962028 [TBL] [Abstract][Full Text] [Related]
9. [The indication of steroid pulse therapy and apheresis therapy for multiple sclerosis]. Ohji S; Nomura K Nihon Rinsho; 2008 Jun; 66(6):1127-32. PubMed ID: 18540358 [TBL] [Abstract][Full Text] [Related]
10. Plasmapheresis in multiple sclerosis: prospective trial of pheresis and immunosuppression versus immunosuppression alone. Tindall RS; Walker JE; Ehle AL; Near L; Rollins J; Becker D Neurology; 1982 Jul; 32(7):739-43. PubMed ID: 7201110 [TBL] [Abstract][Full Text] [Related]
11. Plasma exchange therapy in steroid-unresponsive relapses in patients with multiple sclerosis. Trebst C; Reising A; Kielstein JT; Hafer C; Stangel M Blood Purif; 2009; 28(2):108-15. PubMed ID: 19521072 [TBL] [Abstract][Full Text] [Related]
12. Increased antibody production in peripheral blood mononuclear cells after plasma exchange therapy in multiple sclerosis. Dau PC J Neuroimmunol; 1995 Nov; 62(2):197-200. PubMed ID: 7499508 [TBL] [Abstract][Full Text] [Related]
13. Plasma exchange in neurological diseases. A critical approach. Valbonesi M; Garelli S Vox Sang; 1983; 44(2):65-80. PubMed ID: 6187131 [TBL] [Abstract][Full Text] [Related]
14. Lymphocytapheresis in chronic progressive multiple sclerosis: results of a preliminary trial. Rose J; Klein H; Greenstein J; McFarlin D; Gerber L; McFarland H Ann Neurol; 1983 Nov; 14(5):593-4. PubMed ID: 6651245 [No Abstract] [Full Text] [Related]
17. Relapse of multiple sclerosis following acute allergic reactions to plasma during plasmapheresis. Wirguin I; Shinar E; Abramsky O J Neurol; 1989 Jan; 236(1):62-3. PubMed ID: 2915232 [TBL] [Abstract][Full Text] [Related]
18. [Plasmapheresis in acute phase of multiple sclerosis and neuromyelitis optica]. Matsuo H Nihon Rinsho; 2014 Nov; 72(11):1999-2002. PubMed ID: 25518384 [TBL] [Abstract][Full Text] [Related]
19. Response to Therapeutic Plasma Exchange as a Rescue Treatment in Clinically Isolated Syndromes and Acute Worsening of Multiple Sclerosis: A Retrospective Analysis of 90 Patients. Ehler J; Koball S; Sauer M; Mitzner S; Hickstein H; Benecke R; Zettl UK PLoS One; 2015; 10(8):e0134583. PubMed ID: 26244762 [TBL] [Abstract][Full Text] [Related]
20. [Plasmapheresis: its use in multiple sclerosis and other demyelinating processes of the central nervous system. An observation study]. Meca-Lallana JE; Rodríguez-Hilario H; Martínez-Vidal S; Saura-Luján I; Carretón-Ballester A; Escribano-Soriano JB; Martín-Fernández J; Genovés-Aleixandre A; Mateo-Bosch E; Fernández-Barreiro A Rev Neurol; 2003 Nov 16-30; 37(10):917-26. PubMed ID: 14634919 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]